RETATRUTIDE 20MG — Advanced Triple-Receptor Peptide
Retatrutide is a next-generation investigational peptide designed to target three key metabolic pathways simultaneously: GLP-1, GIP, and Glucagon receptors. This triple-agonist mechanism has positioned Retatrutide as one of the most advanced compounds currently being researched for metabolic optimization, body composition support, and glucose regulation.
Research suggests Retatrutide may support:
- Appetite regulation and satiety
- Improved insulin sensitivity
- Enhanced glucose metabolism
- Increased metabolic activity and energy expenditure
- Advanced fat-loss support within structured protocols
Its unique multi-receptor activity differentiates it from traditional GLP-1 compounds by combining appetite control with potential metabolic and thermogenic support.
Product Details
- Compound: Retatrutide
- Concentration: 20MG Lyophilized Peptide
- Format: Research vial
- Storage: Refrigerated after reconstitution
- Grade: Research Use Only
Important Notice
This product is intended strictly for laboratory and research purposes only.
Not intended for human consumption, diagnosis, treatment, or prevention of any disease.